sailajabyrisetty's blog

When I was reading one of the Canadian Pharmacy Journals I found this article interesting, seems there is good news for asthma patients, now they don't have to use too many puffers such as rescue therapy, maintenance therapy... looks like "All-in-one"......

Hi friends! We all know that the production of ozone-depleting chlorofluorocarbons (CFCs) was discontinued on 1 January 1996 for all uses deemed non-essential under the Montreal Protocol and the use of CFCs as propellants in pressurized metered dose inhalers (MDIs) was classed as essential. The hydrofluoroalkanes (HFA) 134a and 227 were identified as the only suitable replacements for CFC propellants in MDIs.

Isn't it strange, "Doxycycline" is now available as "Anti-inflammatory", NOT an anti-microbial drug, for "Rosacea" patients.  It seems "Oracea (Doxycycline 40 mg) is the first and only anti- inflammatory dose doxycycline for rosacea.

ORACEA is a 40 mg capsule of doxycycline, containing 30 mg immediate release and 10 mg delayed release beads. Once daily 40 mg Oracea significantly reduces inflammatory lesions of rosacea in adult patients.

 I would like to share the moments of "Be Heart Healthy" clinic day...... 

Hi friends! I have exciting moments to share with you! Since February is a heart month, the pharmacy where I am working, conducted a "Be Heart Healthy" clinic (A small set up in front of the pharmacy with information broachers etc..,).  It was actually conducted on February 21^st, 2007, exciting thing is, I was in charge of the clinic. So, I would like to share the experiences with you all.

Hi friends! Did you hear this;

Abbott Laboratories introduced a new Antibiotic FACTIVE into the market! Yesterday I found this news when I was reading a "Pharmacy Post", Canada's Drug Store news magazine, February,2007 edition.

Baraclude:

Baraclude (entecavir by Bristol-Myers Squibb Canada) is a new oral antiviral agent indicated for the treatment of chronic hepatitis B infection.

Tobacco smoking is the leading cause of premature death in developed countries.  Approximately half of all long-term smokers die prematurely due to smoking-related health problems, and continuing smokers have a reduced lifespan by an average of ten years.  In contrast, individuals who quit smoking by age 50 reduce their risk of dying in the following 15 years by about one-half compared with those who continue to smoke.